Kumukūʻai hoʻokūkū no ka hale kūʻai nui Organic Intermediate BMK Pmk Powder 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino] - CAS 22563-90-2

"ʻO ka maikaʻi mua loa, ka ʻoiaʻiʻo e like me ke kumu, kōkua ʻoiaʻiʻo a me ka loaʻa kālā" ko mākou manaʻo, i ka hoʻoikaika ʻana e hana mau a hahai i ka maikaʻi no ke kumukūʻai hoʻokūkū no ka Factory Wholesale Organic Intermediate BMK Pmk Powder 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino]- CAS 22563-90-2, ʻO ke kūlana kiʻekiʻe ke kumu nui no ia hui e kū i waho o nā mea hoʻokūkū ʻē aʻe.ʻO ka ʻike ʻana ʻo Believing, makemake ʻoe i ka ʻike hou aku?E hoʻāʻo wale i kāna mau mea!
"ʻO ka maikaʻi mua loa, ʻo ka ʻoiaʻiʻo e like me ke kumu, kōkua ʻoiaʻiʻo a me ka loaʻa kālā" ko mākou manaʻo, i ka hoʻoikaika ʻana e hana mau a hahai i ka maikaʻi no kaNā Kūwaena Laʻau Lapaʻau Kina a me nā Kūwaena Agrochemical, No ka loaʻa ʻana o ka ʻike hou aku e pili ana iā mākou a me ka ʻike ʻana i kā mākou mea kūʻai āpau, e ʻoluʻolu e kipa i kā mākou pūnaewele.No ka loaʻa ʻana o ka ʻike hou aku e ʻoluʻolu e ʻae iā mākou e ʻike.Mahalo nui iā ʻoe a manaʻo e maikaʻi mau kāu ʻoihana!

3′-Amino-2′-hydroxy-[1,1'-bipheny]-3-carboxylic acid ua hoʻohana ʻia ma ke ʻano waena o Eltrombopag.
ʻO Eltrombopag, i hoʻomohala ʻia e GlaxoSmithKline (GSK) ma UK a ma hope i hoʻomohala pū ʻia me Novartis ma Switzerland, ʻo ia ka mea mua a ʻae wale ʻia ka mole liʻiliʻi non peptide TPO receptor agonist ma ka honua.Ua ʻae ʻia ʻo Eltrombopag e ka US FDA ma 2008 no ka mālama ʻana i ka idiopathic thrombocytopenic purpura (ITP), a ma 2014 no ka mālama ʻana i ka anemia aplastic koʻikoʻi (AA).ʻO ia ka lāʻau lapaʻau mua i ʻae ʻia e ka US FDA no ka mālama ʻana iā AA i nā makahiki he 30 i hala iho nei.
Ma December2012, ua apono ka US FDA ia Eltrombopag no ka lapaau ana i ka thrombocytopenia i na ma'i me ka ma'i hepa C (CHC), i hiki i na ma'i hepa C me ka ilihune prognosis ma muli o ka helu platelet ha'aha'a hiki ke ho'omaka a mālama i ka interferon ma muli o ka ma'i ma'i o ka ate.Ma Feberuari 3,2014, ua hoʻolaha ʻo GlaxoSmithKline ua hāʻawi ka FDA i ka hōʻailona lāʻau lapaʻau holomua o Eltrombopag no ka mālama ʻana i ka hemopenia i nā maʻi me ka puke kemika aplastic anemia (SAA) ʻaʻole i pane piha i ka immunotherapy.Ma ʻAukake 24, 2015, ua ʻae ka US FDA iā Eltrombopag no ka mālama ʻana i ka thrombocytopenia i nā pākeke a me nā keiki o 1 makahiki a ʻoi aku me ka thrombocytopenia immune maʻi (ITP) i lawa ʻole ka pane ʻana i nā corticosteroids, immunoglobulins a splenectomy.Ma Ianuali4,2018, ua ʻae ʻia ʻo Eltrombopag e papa inoa ma Kina no ka mālama ʻana i ka thrombocytopenia immune mua (ITP).

"ʻO ka maikaʻi mua loa, ka ʻoiaʻiʻo e like me ke kumu, kōkua ʻoiaʻiʻo a me ka loaʻa kālā" ko mākou manaʻo, i ka hoʻoikaika ʻana e hana mau a hahai i ka maikaʻi no ke kumukūʻai hoʻokūkū no ka Factory Wholesale Organic Intermediate BMK Pmk Powder 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino]- CAS 22563-90-2, ʻO ke kūlana kiʻekiʻe ke kumu nui no ia hui e kū i waho o nā mea hoʻokūkū ʻē aʻe.ʻO ka ʻike ʻana ʻo Believing, makemake ʻoe i ka ʻike hou aku?E hoʻāʻo wale i kāna mau mea!
Kumukūʻai hoʻokūkū noNā Kūwaena Laʻau Lapaʻau Kina a me nā Kūwaena Agrochemical, No ka loaʻa ʻana o ka ʻike hou aku e pili ana iā mākou a me ka ʻike ʻana i kā mākou mea kūʻai āpau, e ʻoluʻolu e kipa i kā mākou pūnaewele.No ka loaʻa ʻana o ka ʻike hou aku e ʻoluʻolu e ʻae iā mākou e ʻike.Mahalo nui iā ʻoe a manaʻo e maikaʻi mau kāu ʻoihana!